AzTrials
AzTrials

HealthyMEEGOPTINCT06297057

Acquisition and Analysis Protocol Optimization of Neurophysiological Data Neurorehabilitation Settings

A study testing Neurophysiological Recordings in people with Healthy, run by IRCCS San Camillo, Venezia, Italy at 1 site in Italy.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The study aims to optimize and validate protocols for acquiring neurophysiological data, specifically resting state functional connectivity, using advanced research techniques (hdEEG and MEG) and a user-friendly device (MUSE). Read more about this study

Who is it for?
Ages 18 to 45 yearsHealthy volunteers can take part
Conditions the study is for
Healthy
What is being tested?
Neurophysiological Recordings
Could I receive a placebo?
No, everyone receives an active treatment
How many people
15 participants
Where
1 siteItaly
Study dates
Mar 2024to Mar 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 45 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • age between 18 and 65
  • ability to sign an informed consent form

Who cannot join

  • has suffered/is suffering from epileptic seizures.
  • has had severe neurological or psychiatric disorders
  • has eyesight problems that prevent him/her from reading, which she cannot correct with contact lenses (she will not be able to wear glasses during registration)
  • habitually abused drugs or abused alcoholic substances
  • has abused substances such as alcohol or drugs in the last three days
  • is a wearer of hearing aids
Show all 17Show fewer
  • has metal and/or skull clips or other metal in any part of the head except the mouth
  • has non-removable tattoos
  • has piercings, earrings or other metal accessories that cannot be removed.
  • is or could be pregnant (pregnancy in the first trimester)
  • is a carrier of sickle cell anaemia
  • is a cardiac pacemaker wearer or has an artificial heart valve
  • has mechanical devices that he/she uses to administer medication
  • has a surgical clip (vascular clips and metallic arterial prostheses made of ferromagnetic material)
  • has a cochlear implant, a neurostimulator or a programmable hydrocephalic electrical conductor (shunt)
  • has had brain surgery
  • has implants or metal fragments in the body

Trial locations and contacts

1 site in 1 country.

Italy1 site
  • San Camillo IRCCS s.r.l.

    Venice-Lido, Venice, 30126

Other trials in Italy

About this study

Official title: Acquisition and Analysis Protocol Optimization of Neurophysiological Data in Neurorehabilitation Setting: Pilot Study on Healthy Subjects

The study aims to optimize and validate protocols for acquiring neurophysiological data, specifically resting state functional connectivity, using advanced research techniques (hdEEG and MEG) and a user-friendly device (MUSE). Previous studies have extensively explored functional connectivity repeatability in resting conditions using functional MRI, yet few have focused on hdEEG and MEG data. Additionally, the impact of subjects' eye conditions (open or closed) during resting state recordings on network identification remains debated.

The investigation involves assessing the effect of eye conditions on brain network identification and determining the most stable and repeatable measures of functional connectivity over time. This analysis is crucial for discerning whether observed changes in patients' functional connections are intrinsic to the methodology or indicative of genuine physiological alterations.

Read more

The study aims to optimize protocols for rehabilitation by evaluating changes in functional connectivity metrics during and between experimental sessions. Furthermore, it seeks to identify the conditions (eyes closed or open) that yield more reliable and repeatable functional measurements.

Following the optimization of advanced techniques, the study explores the feasibility of utilizing the MUSE EEG system in clinical settings. MUSE, known for its portability and user-friendliness, has demonstrated quality in experimental psychology and clinical research. The objective is to establish relevant functional correspondences between measurements obtained through research techniques (hdEEG and MEG) and those acquired with MUSE.

The primary goal is to establish a protocol highlighting subjects' responses to acoustic stimuli or a reproducible pattern of resting state activity. The secondary objectives include investigating temporal and spatial characteristics of neurophysiological signals in healthy subjects over time and defining prognostic biomarkers for monitoring patients undergoing rehabilitation. This comprehensive approach aims to enhance the understanding of resting state functional connectivity and its applications in clinical settings.

Therefore, to meet these goals, the present study will consist of multiple recordings of brain activity: by high-density electroencephalography (hdEEG), magnetoencephalography (MEG), and low-density EEG with a MUSE handheld device, during five experimental blocks on healthy subjects.

Read the detailed description

Participants who will be identified as suitable for hdEEG, MEG, and MUSE recording will first undergo a neuronavigation session, and then three identical neurophysiological data acquisition sessions, one for hdEEG, one for MEG, and one for MUSE.

The sessions will take place in three consecutive weeks, once a week, taking care that these recordings are made at the same time of day for each participant. Finally, a structural magnetic resonance imaging (MRI) recording will be obtained for each participant.

Each neurophysiological data acquisition session will consist of 5 blocks: 4 eyes-open and eyes-closed resting-state blocks, and one passive auditory stimulation block.

The four blocks in the resting condition will always be performed first, to avoid interference due to the passive acoustic task. The order of blocks 1 and 2, and consequently also blocks 3 and 4, representing the open-eye and closed-eye conditions will be counterbalanced between participants and between different sessions for the same participant.

Conditions
Healthy
Being tested
Neurophysiological Recordings
Keywords
connectivity, MEEG, resting state, Mismatch Negativity (MMN), Auditory Steady State Response (ASSR)

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Neurophysiological RecordingsOther

    Eyes-open resting-state blocks: these blocks will last 5 minutes each. Subjects will be asked to relax and not think about anything specific, keeping their eyes open and staring at a white cross in the center of a light grey screen to limit their eye movements.

    Eyes-closed resting-state blocks: these blocks will last 5 minutes each. Subjects will be asked to relax and not think about anything specific, keeping their eyes closed.

    ASSR: this block will last approximately 6 minutes. Stimuli will consist of a train of sounds presented repeatedly at high frequency.

    MMN: this block will last approximately 3 minutes. Stimuli will consist of a train of equal sounds presented alternating with a 'deviant' (rarer frequency) sound.

Study groups in NCT06297057
Study groupRoleWhat they receive
Neurophysiological RecordingsExperimentalParticipants suitable for hdEEG, MEG, and MUSE recordings will first undergo a neuronavigation session, and then three identical neurophysiological data acquisition sessions, one for hdEEG, one for MEG, and one for MUSE. The sessions will take place in three consecutive weeks, once a week, taking care that they are made at the same time of day for each participant. Finally, a structural magnetic resonance imaging (MRI) recording will be obtained for each participant. Each neurophysiological data acquisition session will consist of 5 blocks: 4 eyes-open and eyes-closed resting-state blocks, and one passive auditory stimulation block. The four blocks in the resting condition will be performed first, to avoid interference due to the passive acoustic task. The order of blocks 1 and 2, and consequently also blocks 3 and 4, representing the open-eye and closed-eye conditions will be counterbalanced between subjects and between different sessions for the same subject.
Receives: Other: Neurophysiological Recordings

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Neurophysiological data acquisition protocol - resting state

    Resting state measure from MEEG data: Power spectrum density values (delta, theta, alpha, beta, gamma frequency)

    Measured: T1: first week, T2: second week, T3: third week

  2. Neurophysiological data acquisition protocol - resting state

    Resting state measure from MEEG data: Connectivity values at source level (delta, theta, alpha, beta, gamma frequency)

    Measured: T1: first week, T2: second week, T3: third week

  3. Neurophysiological data acquisition protocol - auditory stimulation

    ASSR response (as measured from auditory stimulation)

    Measured: T1: first week, T2: second week, T3: third week

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Mar 2024
  2. Study startMar 2024 (estimated)
  3. Primary completionMar 2025 (estimated)
  4. Study completionMar 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
15 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06297057
Sponsor's protocol ID
2021.07
Acronym
MEEGOPTI
Status last verified
Feb 2024
First submitted
8 Feb 2024
Last updated
6 Mar 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Neurophysiological Recordings in people with Healthy, run by IRCCS San Camillo, Venezia, Italy at 1 site in Italy.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 17 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 6 Mar 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Neurophysiological data acquisition protocol - resting state (time frame: T1: first week, T2: second week, T3: third week). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Mar 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in